IMMUNIC INC's ticker is IMUX and the CUSIP is 4525EP101. A total of 54 filers reported holding IMMUNIC INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $826,884 | -39.0% | 562,506 | +4.2% | 0.15% | -35.3% |
| Q2 2023 | $1,354,780 | +97.8% | 539,753 | +17.4% | 0.24% | +57.7% |
| Q1 2023 | $685,057 | +6.4% | 459,770 | 0.0% | 0.15% | -12.9% |
| Q4 2022 | $643,678 | -69.0% | 459,770 | -30.1% | 0.17% | -71.1% |
| Q3 2022 | $2,078,000 | -7.9% | 657,643 | +1.2% | 0.59% | -28.9% |
| Q2 2022 | $2,256,000 | -81.7% | 650,028 | -40.3% | 0.83% | -76.9% |
| Q1 2022 | $12,309,000 | +32.0% | 1,089,251 | +11.8% | 3.60% | +75.1% |
| Q4 2021 | $9,323,000 | +14.0% | 974,183 | +5.4% | 2.06% | -0.6% |
| Q3 2021 | $8,178,000 | +61.1% | 924,087 | +123.2% | 2.07% | +86.4% |
| Q2 2021 | $5,077,000 | -20.6% | 414,087 | +3.2% | 1.11% | -25.2% |
| Q1 2021 | $6,395,000 | +14.1% | 401,218 | +9.4% | 1.48% | +3.3% |
| Q4 2020 | $5,607,000 | -24.5% | 366,691 | -8.3% | 1.44% | -26.9% |
| Q3 2020 | $7,428,000 | +337.7% | 400,023 | +185.7% | 1.97% | +311.5% |
| Q2 2020 | $1,697,000 | – | 140,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 1,000,000 | $1,400,000 | 0.88% |
| Omega Fund Management, LLC | 1,788,160 | $2,503,424 | 0.84% |
| COMMODORE CAPITAL LP | 1,800,000 | $2,520 | 0.38% |
| Ikarian Capital, LLC | 650,000 | $910,000 | 0.22% |
| Gratus Capital, LLC | 1,668,294 | $2,335,612 | 0.19% |
| GREAT POINT PARTNERS LLC | 632,184 | $885,058 | 0.17% |
| Parkman Healthcare Partners LLC | 459,770 | $643,678 | 0.17% |
| Anson Funds Management LP | 664,935 | $930,909 | 0.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 350,656 | $490,918 | 0.14% |
| COWEN AND COMPANY, LLC | 791,024 | $1,107,433 | 0.12% |